A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?
RSS SUMMARY · AGGREGATED FROM TNYT
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
Continue Reading
The full story continues on The New York Times.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TNYT
US
Eric Swalwell Won More Than 18,000 Votes Despite Suspending His Campaign
TNYT·1h ago·3 min read
US
House Advances New Sanctions on Russia and Aid to Ukraine
TNYT·1h ago·3 min read
Politics
Park Service Awards No-Bid Contract to Cover Bridge Statues in Gold
TNYT·1h ago·3 min read
World News
Musk and Trump Slashed Aid. Now We Lack Tools to Tackle Ebola.
TNYT·1h ago·3 min read
Related
On this beat
Health
An Uncertain Path for Americans Exposed to Ebola
TNYT·3h ago·3 min read
Health
Autism therapy has attracted predatory providers who bill for phantom services, pad hours and charge steep fees for care delivered by low-paid workers. Here are five takeaways from a WSJ investigation
TWSJ·6h ago·3 min read
Health
New research could help doctors tweak anesthesia to more resemble natural sleep, reducing risks
TWSJ·7h ago·3 min read
Health
Diets high in ultraprocessed foods are associated with an increased risk of dementia, a new study says, adding to the list of health problems linked to foods such as cookies, hot dogs and pizza
TWSJ·13h ago·3 min read